Cleared Traditional

LANDMARK REBOA Catheter

K214060 · Zien Medical Technologies, Inc. · Cardiovascular
Sep 2022
Decision
266d
Days
Class 2
Risk

About This 510(k) Submission

K214060 is an FDA 510(k) clearance for the LANDMARK REBOA Catheter, a Catheter, Intravascular Occluding, Temporary (Class II — Special Controls, product code MJN), submitted by Zien Medical Technologies, Inc. (Salt Lake City, US). The FDA issued a Cleared decision on September 19, 2022, 266 days after receiving the submission on December 27, 2021. This device falls under the Cardiovascular review panel. Regulated under 21 CFR 870.4450.

Submission Details

510(k) Number K214060 FDA.gov
FDA Decision Cleared SESE
Date Received December 27, 2021
Decision Date September 19, 2022
Days to Decision 266 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Summary PDF

Device Classification

Product Code MJN — Catheter, Intravascular Occluding, Temporary
Device Class Class II — Special Controls
CFR Regulation 21 CFR 870.4450

Similar Devices — MJN Catheter, Intravascular Occluding, Temporary

All 89
pREBOA-PRO Catheter
K243795 · Prytime Medical Devices, Inc. · Sep 2025
Bridge Plus Occlusion Balloon (590-002)
K251358 · Philips Image Guided Therapy Devices · Jun 2025
preCARDIA Occlusion System
K221294 · Abiomed, Inc. · Jun 2023
Fogarty Occlusion Catheter
K211610 · Edwards Lifesciences, LLC · Feb 2022
RenovoCath
K212324 · Renovorx, Inc. · Aug 2021
AortaSTAT Occlusion Device
K210602 · Renalpro Medical, Inc. · Jul 2021